Закажите звонок



Ваша заявка успешно отправлена. В ближайшее время с Вами свяжется наш специалист.

List of publications for


European Science Review, Issue 1-2/2017

Polymorphisms (rs1048943) (1799853) (rs 2740574) of СYP1 А1, СYP2 С9, СYP3 А4 genes at Uzbek population

DOI: https://doi.org/10.29013/ESR-17-1.2-65-67

Pages: 65 - 67

Authors: Abdurakhmanova N. N.

Abstract: Clinically important genes СYP1 А1, СYP2 С9, СYP3 А4 were studied for the first time in Uzbek population, for 217 healthy voluntaries. The frequencies of minor alleles СYP1 А1*2 С, СYP2 С9*2, СYP3 А4*1 В were 6,7, 9,4, and 3,2% respectively and corresponded to Caucasian. For 3 alleles the genotype frequencies were in accordance with Hardy–Weinberg equilibrium. The absence of homozygous СYP1 А1*2 С, СYP2 С9*2, СYP3 А4*1 В was revealed. 86,6, 81,1, and 93,5% were homozygous for wild alleles, 13,4, 18,9 и 6,5% were heterozygotes СYP1 А1*2 С, СYP2 С9*2, СYP3 А4*1 В respectively. The intermediate surplus of observed heterozygotes on expected heterozygotes was shown for СYP1 А1*2 С, СYP2 С9*2.

Keywords: СYP1 А1, СYP2 С9, СYP3 А4, Uzbek population

1. Rendic S., Guengerich P. Survey of Human Oxidoreductases and Cytochrome – P. 450. Enzymes Involved in the Metabolism of Xenobiotic
and Natural Chemicals//Chem. Res. Toxicol. – 2015. – V.28. – No. 1. – C. 38–42.
2. Wahlang B., Falkner K. C., Cave M. C., Prough R. A. Role of Cytochrome P450 Monooxygenase in Carcinogen and Chemotherapeutic
Drug Metabolism//Advances in Pharmacology. – 2015. – V. 74. – C. 1–33.
3. Wells R., Yuldasheva N., Ruzibakiev R., Underhill P., Evseeva I., Blue-Smith J., Jin L., Su B., Pitchappan R., Shanmugalakshmi S., Balakrishnan
K., Read M., Pearson N. M., Zerjal T., Webster M. T., Zholoshvili I., Jamarjashvili E., Gambarov S., Nikbin B., Dostiev A.,
Aknazarov O., Zalloua P., Tsoy I., Kitaev M., Mirrakhimov M., Chariew A., Bodmer W. The Eurasian heartland: a continental perspective
on Y – chromosome diversity//Proc Natl Acad Sci. – 2001. – V. 98. – C. 10244–10249.
4. Irwin J. A., Ikramov A., Saunier J., Bodner M., Amory S., Röck A., O’Callaghan J., Nuritdinov A., Atakhodjaev S., Mukhamedov R.,
Parson W., Parsons T. J. The mtDNA composition of Uzbekistan: a microcosm of Central Asian patterns//Int J Legal Med. – 2010. – V.
124. – C. 195–204.
5. Inoue K., Asao T., Shimada T. Ethnic-related differences in the frequency distribution of genetic polymorphisms in the CYP1A1 and
CYP1B1 genes in Japanese and Caucasian populations//Xenobiotica. – 2000. – V. 30. – C. 285–295.
6. Zhan P., Wang Q., Qian Q., Wei S. Z., Yu L. K. CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated metaanalysis
and review//J. of Experimental & Clinical Cancer Research. – 2011. – Т. 30. – No 1. – С. 1–17.
7. Céspedes-Garro C., I. Fricke-Galindo, M. Naranjo, F. Rodrigues-Soares, H. Fariñas, F.de Andrés, M. López-López, E. Peñas-Lledó,
A. LLerena Worldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypes//Expert Opin.
Drug Metab. Toxicol. – 2015. – V. 11. – No. 12. – C. 1893–1905.
8. Keshava C., McCanlies E., Weston A. Cyp 3A4 polymorphisms potential risk factors for breast and prostate cancer: a huge review//Am
J Epidemiol. – 2004. – V. 160. – C. 825–841.
Current state of the problem sudden infant death at home
9. Lee J. S., Cheong H. S., Kim L. H., Kim J. O., Seo D. W., Kim Y. H., Chung M. W., Han S. Y., Shin H.D Screening of genetic polymorphisms
of CYP3A4 and CYP3A5 genes//The Korean Journal of Physiology & Pharmacology. – 2013. – Т. 17. – No. 6. – С. 479–484.
10. Zhang J., Jin T., Yunus Z., Li X., Geng T., Wang H., Cui Y., Chen C. Genetic polymorphisms of VIP variants in the Tajik ethnic group
of northwest China//BMC genetics. – 2014. – V.15. – No. 1. – C. 1–9.
11. Razmkhah F., Pazhakh V., Zaker F., Atashrazm F., Sheikhi M. Frequency of CYP1A1*2C polymorphism in patients with leukemia in
the Iranian population//Laboratory Medicine. – 2011. – Т. 42. – No. 4. – С. 220–223.
12. Hashemi-Soteh S., Shahabi-Majd N., Gholizadeh A.-R., Shiran M.-R. Allele and Genotype frequencies of CYP2C9 within an Iranian
population (Mazandaran)//Genetic testing and molecular biomarkers. – 2012. – V. 16. –No. 7. – C. 817–821.
13. Badavi E., Safavi B., Jalali A., Shahriary G., Mohammadi-Asl J., Babaei, J. Association of CYP3A4 and CYP3A5 polymorphisms with Iranian
breast cancer patients//Egyptian J. of Med Hum Genetics. – 2015. – Т. 16. – No 3. – С. 219–225.
14. Jin T., Xun X., Du S., Geng T., Wang H., Feng T., Chen C., Yuan D., Kang L. Genetic polymorphisms analysis of drug-metabolizing
enzyme CYP2C9 in the Uyghur population//Xenobiotica. – 2016. – Т. 46. – No. 8. – С. 709–714.